SLIDE 1
Age-Related Macular Degeneration Past Present & Future - - PowerPoint PPT Presentation
Age-Related Macular Degeneration Past Present & Future - - PowerPoint PPT Presentation
Age-Related Macular Degeneration Past Present & Future Cynthia J. MacKay, MD Clinical Professor of Ophthalmology Columbia University College of Physicians and Surgeons (Emeritus) Age-related Macular Degeneration (AMD) 1 AMD is #1
SLIDE 2
SLIDE 3
AMD: SYMPTOMS
1 Loss of detail: reading driving faces 2 Need for more light 3 Difficulty adapting to light/dark 4 Blank spots 5 Decreased color vision – esp. blues 6 Distortion (See ophthalmologist that day)
SLIDE 4
SLIDE 5
SLIDE 6
SLIDE 7
Normal Fundus (Back of Eye)
SLIDE 8
Normal Retina
Dry Age-Related Macular Degeneration: Drusen & RPE Atrophy
SLIDE 9
SLIDE 10
A gene for Age-Related Macular Degeneration has been identified* on chromosome one (2005) This may allow for targeted treatment The gene codes for complement factor H *Josephine Hoh at Yale School of Medicine, and colleagues from Yale, Rockefeller University and the National Eye Institute.
SLIDE 11
Dry Macular Degeneration What to avoid
Ocuvite/Preservision “Stem Cell Tourism”
SLIDE 12
THE FUTURE
1 Complement inhibition: disappointing except for Complement factor I (“gene testing will tailor therapy”) 2 Gene therapy with adenovirus vector: two phase-2 trials of anti-VEGF for wet AMD 3 Long-acting pellets for wet AMD 4 Ongoing trial: high dose (80 mg) Lipitor 5 Reconstruction of RPE by transplant: Gouras, fetal RPE; NEI, 1/16/16, blood cell converted to RPE cell
SLIDE 13
RPE Transplant Technique
SLIDE 14
Transforming Blood Cell into RPE Cell
SLIDE 15